ACTRN12617000102370已完成1 期
A randomized, double-blinded, placebo-controlled study in healthy, non-immune adults to determine the schizonticidal activity of tafenoquine after challenge with Plasmodium falciparum blood stage parasites.
60 Degrees Pharmaceuticals Australia (60P) Pty Ltd0 个研究点目标入组 16 人开始时间: 2017年1月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
adalimumab intralesional in intestinal strictures of Crohn's disease patientsCrohn diseaseMedDRA version: 16.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2012-001723-12-ESFundació Clínic per a la Recerca Biomèdica102
进行中（未招募）
1 期
A study of Rituximab treatment in patients with Psychosis an/or Obsessive Compulsive Disorder, with a suspected involvement of the immune systemEUCTR2019-000256-33-SEppsala University Hospital40
进行中（未招募）
1 期
To study the antidepressive effects of the endogen compound NPY in patients with depression.Major depressive disorderMedDRA version: 18.0Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873EUCTR2014-000129-19-SEKarolinska University Hospital, Huddinge70
进行中（未招募）
1 期
A study to determine the added value of vitamin D3 to treatment with subcutaneous immunotherapy in patients with birch pollen allergysubcutaneous immunotherapy in allergic rhinitis (AR) patients with allergies to birchpollenEUCTR2018-001339-33-NLAcademisch medisch centrum Amsterdam40
尚未招募
Unknown
A randomized, double-blind, placebo-controlled, parallel study with an open label placebo extensioCTRI/2023/05/052481Vidya Herbs Pvt Ltd